Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan
Abstract Background Real-world impact of extended-release formulations of oral drugs should ideally be evaluated in population-based health data. Objective To evaluate changes in utilization of the dopamine agonist pramipexole for Parkinson's disease after the introduction of extended-release (...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Adis, Springer Healthcare,
2020-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|